APLIF: New Late Stage Program to Treat Cutaneous Leishmaniasis…
Bautz: By David Bautz, PhD
OTC:APLIF | TSX:APLI.TO
READ THE FULL APLIF RESEARCH REPORT
Aditxt Signs Share Exchange Agreement to Acquire AiPharma in Cash, Stock Deal
Aditxt Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, has signed a share exchange agreement to acquire AiPharma Global Holdings LLC, a wholly-owned subsidiary of AiPharma Group Ltd. ("AiPharma").
APLIF: PRESECO Trial Unsuccessful in COVID-19…
By David Bautz, PhD
OTC:APLIF | TSX:APLI.TO
READ THE FULL APLIF RESEARCH REPORT
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Aditxt Inc (NASDAQ:ADTX) has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral therapies. AiPharma Global…
APLIF: Awaiting Data Readout for Phase 3 PRESECO Trial in COVID-19…
By David Bautz, PhD
OTC:APLIF | TSX:APLI.TO
READ THE FULL RESEARCH REPORT